ImportRefusal LogoImportRefusal

Karen Laboratorio, S.A. de C.V.

⚠️ Moderate Risk

FEI: 3004274421 • Pueblo San Simon, Mexico • MEXICO

FEI

FEI Number

3004274421

📍

Location

Pueblo San Simon, Mexico

🇲🇽

Country

MEXICO
🏢

Address

Avenida Rio Chiquito No. 2, Texcoco, Pueblo San Simon, Mexico, Mexico

Moderate Risk

FDA Import Risk Assessment

30.1
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

3
Total Refusals
9
Unique Violations
5/26/2020
Latest Refusal
5/19/2020
Earliest Refusal

Score Breakdown

Violation Severity
51.0×40%
Refusal Volume
22.3×30%
Recency
0.0×20%
Frequency
30.0×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

2183×

LIST INGRE

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(i)(2) of the FD&C Act in that it is fabricated from two or more ingredients and the label fails to bear the common or usual name of each such ingredient and/or the article purports to be a beverage containing vegetable or fruit juice, but does not bear a statement with appropriate prominence on the information panel of the total percentage of such fruit or vegetable juice contained in the food.

4823×

NUTRIT LBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling fails to bear the required nutrition information.

4883×

HEALTH C

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be misbranded in that the label or labeling bears an unauthorized nutrient content/health claim.

753×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

38642×

NCONTACT

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(y) of the FD&C Act in that the dietary supplement label fails to bear a domestic address or phone number through which the responsible person (as described in section 761 of the FD&C Act) may receive a report of a serious adverse event with such dietary supplement.

4732×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

38632×

PLANT PART

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(C) of the FD&C Act in that the supplement contains an herb or other botanical described in section 201(ff)(1)(C), and the label or labeling of the supplement fails to identify any part of the plant from which the ingredient is derived.

23001×

DIETARYLBL

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it is a dietary supplement that appears to be misbranded within the meaning of Section 403(s)(2)(B) of the FD&C Act in that the label or labeling fails to identify the product by using the term "dietary supplement", which term may be modified with the name of such an ingredient.

3201×

LACKS FIRM

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the FD&C Act in that it appears to be misbranded within the meaning of Section 403(e)(1) of the FD&C Act in that the food is in package form and the label fails to bear the name and place of business of the manufacturer, packer, or distributor.

Refusal History

DateProductViolationsDivision
5/26/2020
41EYY99MEAL REPLACEMENTS (NOT LABELED FOR TREATMENT OF DISEASE)
218LIST INGRE
320LACKS FIRM
473LABELING
482NUTRIT LBL
488HEALTH C
75UNAPPROVED
Division of Southwest Imports (DSWI)
5/20/2020
41EYY99MEAL REPLACEMENTS (NOT LABELED FOR TREATMENT OF DISEASE)
218LIST INGRE
3863PLANT PART
3864NCONTACT
482NUTRIT LBL
488HEALTH C
75UNAPPROVED
Division of Southwest Imports (DSWI)
5/19/2020
41EYY99MEAL REPLACEMENTS (NOT LABELED FOR TREATMENT OF DISEASE)
218LIST INGRE
2300DIETARYLBL
3863PLANT PART
3864NCONTACT
473LABELING
482NUTRIT LBL
488HEALTH C
75UNAPPROVED
Division of Southwest Imports (DSWI)

Frequently Asked Questions

What is Karen Laboratorio, S.A. de C.V.'s FDA import refusal history?

Karen Laboratorio, S.A. de C.V. (FEI: 3004274421) has 3 FDA import refusal record(s) in our database, spanning from 5/19/2020 to 5/26/2020.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Karen Laboratorio, S.A. de C.V.'s FEI number is 3004274421.

What types of violations has Karen Laboratorio, S.A. de C.V. received?

Karen Laboratorio, S.A. de C.V. has been cited for 9 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Karen Laboratorio, S.A. de C.V. come from?

All FDA import refusal data for Karen Laboratorio, S.A. de C.V. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.